Polyrizon

Polyrizon is a clinical-stage biotechnology company dedicated to developing innovative nasal gels for preventive treatments against various biological threats, such as viruses, including COVID-19 and influenza, as well as allergens and other airborne pathogens. Polyrizon's proprietary Capture and ContaineTM (C&C) hydrogel platform consists of a mixture of naturally derived building blocks, delivered in the form of a nasal spray, forming a thin protective barrier in the nasal cavity to prevent infections.